Hepatitis C treatment in liver transplant setting.
作者信息
Peyton Adam, Bhamidimarri Kalyan Ram
机构信息
From the Division of Hepatology University of Miami-Miller School of Medicine Miami FL.
出版信息
Clin Liver Dis (Hoboken). 2015 Jun 24;5(6):145-149. doi: 10.1002/cld.475. eCollection 2015 Jun.
Abstract
摘要
相似文献
1
Hepatitis C treatment in liver transplant setting.肝移植患者的丙型肝炎治疗
Clin Liver Dis (Hoboken). 2015 Jun 24;5(6):145-149. doi: 10.1002/cld.475. eCollection 2015 Jun.
2
Treatment of liver transplant recipients who have chronic hepatitis C virus infection.对患有慢性丙型肝炎病毒感染的肝移植受者的治疗。
Exp Clin Transplant. 2014 Mar;12 Suppl 1:28-33. doi: 10.6002/ect.25liver.l23.
3
Pre- Versus Posttransplant Treatment of Hepatitis C Virus With Direct-Acting Antivirals in Liver Transplant Recipients: More Issues to be Solved.肝移植受者中丙型肝炎病毒直接作用抗病毒药物的移植前与移植后治疗：更多待解决的问题
Exp Clin Transplant. 2017 Feb;15(Suppl 1):1-5. doi: 10.6002/ect.mesot2016.L19.
4
Ledipasvir/sofosbuvir without ribavirin is effective in the treatment of recurrent hepatitis C virus infection post-liver transplant.来迪派韦索磷布韦片联合利巴韦林治疗肝移植后复发的丙型肝炎病毒感染有效。
Hepatol Int. 2017 Sep;11(5):434-439. doi: 10.1007/s12072-016-9778-6. Epub 2017 Jan 12.
5
Hepatitis C virus infection can affect lymphoproliferative disorders only as a cofactor for Epstein-Barr virus in liver transplant recipients: PTLD.Int survey.丙型肝炎病毒感染仅作为肝移植受者中 Epstein-Barr 病毒导致淋巴增殖性疾病（PTLD）的一个辅助因素发挥作用：国际调查。
Exp Clin Transplant. 2012 Apr;10(2):141-7. doi: 10.6002/ect.2011.0114.
6
In-hospital post-transplant acute hepatitis A viral (HAV) infection in a liver transplant recipient who was HAV seropositive pre-transplant.移植前甲型肝炎病毒（HAV）血清学阳性的肝移植受者在医院内发生移植后急性HAV感染。
Saudi J Gastroenterol. 2019 Jan-Feb;25(1):67-70. doi: 10.4103/sjg.SJG_230_18.
7
Effectiveness and safety of sofosbuvir/ledipasvir ± ribavirin treatment in liver and/or renal transplant patients with chronic hepatitis C: A single-center experience.索磷布韦/来迪帕司韦±利巴韦林治疗肝和/或肾移植慢性丙型肝炎患者的有效性和安全性：单中心经验
SAGE Open Med. 2018 Jun 5;6:2050312118781416. doi: 10.1177/2050312118781416. eCollection 2018.
8
Shear-wave elastography for the assessment of liver fibrosis in liver transplant recipients treated for hepatitis C virus recurrence.剪切波弹性成像用于评估接受丙型肝炎病毒复发治疗的肝移植受者的肝纤维化。
Eur J Gastroenterol Hepatol. 2018 Jan;30(1):27-32. doi: 10.1097/MEG.0000000000001003.
9
10
Liver Transplant in Young Adults with Chronic Hepatitis C Virus: An Argument for Hepatitis C Treatment in Childhood.慢性丙型肝炎病毒感染的年轻成年人肝移植：支持儿童期丙型肝炎治疗的理由。
Exp Clin Transplant. 2016 Apr;14(2):201-6. doi: 10.6002/ect.2015.0092. Epub 2015 Oct 14.
引用本文的文献
1
Benign course of residual inflammation at end of treatment of liver transplant recipients after sofosbuvir based therapy.基于索磷布韦治疗的肝移植受者治疗结束时残余炎症的良性病程。
World J Hepatol. 2022 Mar 27;14(3):602-611. doi: 10.4254/wjh.v14.i3.602.
本文引用的文献
1
Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 after liver transplant.多中心使用simeprevir 和 sofosbuvir 联合或不联合利巴韦林治疗肝移植后丙型肝炎基因型 1 的经验。
Hepatology. 2015 Jun;61(6):1880-6. doi: 10.1002/hep.27770. Epub 2015 Apr 27.
2
Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.索磷布韦联合利巴韦林治疗肝移植后代偿期复发丙型肝炎病毒感染
Gastroenterology. 2015 Jan;148(1):108-17. doi: 10.1053/j.gastro.2014.10.001. Epub 2014 Oct 7.
3
Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.索磷布韦和利巴韦林可预防肝移植后 HCV 感染复发：一项开放标签研究。
Gastroenterology. 2015 Jan;148(1):100-107.e1. doi: 10.1053/j.gastro.2014.09.023. Epub 2014 Sep 28.
4
A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapy.一项关于采用蛋白酶抑制剂三联疗法对肝移植受者进行丙型肝炎治疗的美国多中心研究。
J Hepatol. 2014 Sep;61(3):508-14. doi: 10.1016/j.jhep.2014.04.037. Epub 2014 May 5.
5
Review article: the treatment of genotype 1 chronic hepatitis C virus infection in liver transplant candidates and recipients.综述文章：肝移植候选者和受者中基因型 1 慢性丙型肝炎病毒感染的治疗。
Aliment Pharmacol Ther. 2013 Apr;37(7):659-71. doi: 10.1111/apt.12260. Epub 2013 Feb 21.
6
Combinations of simple baseline variables accurately predict sustained virological response in patients with recurrent hepatitis C after liver transplantation.简单的基线变量组合可以准确预测肝移植后复发性丙型肝炎患者的持续病毒学应答。
J Gastroenterol. 2013 Jun;48(6):762-9. doi: 10.1007/s00535-012-0680-2. Epub 2012 Sep 26.
7
Comparison of two non-contemporaneous HCV-liver transplant cohorts: strategies to improve the efficacy of antiviral therapy.比较两个非同期 HCV-肝移植队列：提高抗病毒治疗疗效的策略。
J Hepatol. 2012 Jun;56(6):1310-6. doi: 10.1016/j.jhep.2011.12.031. Epub 2012 Feb 5.
8
Hepatitis C virus-infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men.丙型肝炎病毒感染的女性在肝移植后发生晚期纤维化和移植物丢失的风险高于男性。
Hepatology. 2011 Aug;54(2):418-24. doi: 10.1002/hep.24390. Epub 2011 Jun 23.
9
The natural history of recurrent hepatitis C and what influences this.复发性丙型肝炎的自然病史及其影响因素。
Liver Transpl. 2008 Oct;14 Suppl 2:S36-44. doi: 10.1002/lt.21646.
10
Trends in post-liver transplant survival in patients with hepatitis C between 1991 and 2001 in the United States.1991年至2001年美国丙型肝炎患者肝移植术后生存率的趋势。
Liver Transpl. 2007 May;13(5):719-24. doi: 10.1002/lt.21123.
Zotero 插件